Holen Sie sich die Stockscreener-App
20.18
1.13%
-0.23
Abrdn Healthcare Opportunities Fund Aktie (THQ) Neueste Nachrichten
abrdn U.S. Closed-End Funds Announce Distribution Payment Details - Corsicana Daily Sun
Abrdn U.S. Closed-End Funds Announce Distribution Payment Details - WICZ
How abrdn's Latest Fund Distributions Might Impact Your Income Strategy - StockTitan
Bargain Alert: 2 Big Dividends, Up To 10% Yield - Seeking Alpha
Sanctuary Advisors LLC Trims Stake in Abrdn Healthcare Investors (NYSE:HQH) - Defense World
abrdn U.S. Closed End Funds Announce Distribution Payment Details - ACCESS Newswire
Ex-Dividend Reminder: Primerica, Carlyle Group and Abrdn Healthcare Opportunities Fund - Nasdaq
THQ: Improved Performance But Trades At Fair Value - Seeking Alpha
Infrastructure & Healthcare Fund Alert: Two Top CEFs Announce Generous Yields Over 10% - StockTitan
Two Areas of Opportunity for 2025 - Stock Investor
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update - ACCESS Newswire
abrdn Global Infrastructure Income Fund (ASGI) Announces Update and Tentative Closing Date for Acquisition of Assets From First Trust/abrdn Global Opportunity Income Fund - ACCESS Newswire
Fierce Biotech Fundraising Tracker '25: Umoja adds $100M; Normunity nabs $75M - Fierce Biotech
2 Big Dividends To Buy And Hold Forever - Seeking Alpha
A Gift Of Yields Up To 11% - Seeking Alpha
French PE fund Jeito Capital invests in global biopharma growth with Aviceda and XyloCor Therapeutics - EU-Startups
Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials - BioSpace
Jeito Capital announces significant participation in upsized $207.5 million Series C financing in Aviceda Therapeutics to advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials - The Manila Times
HQH: Not For Income Investors - Seeking Alpha
THQ: Healthcare Weakness Presents Opportunity, But Potentially Better Alternatives Exist - Seeking Alpha
My #1 Income Strategy For 2025 (Safety, 14% Dividends On The Table) - Contrarian Outlook
abrdn Private Equity Opportunities (LON:APEO) Trading Down 1% – Here’s What Happened - Defense World
THQ: Tempest On The Horizon (NYSE:THQ) - Seeking Alpha
ACPabrdn Income Credit Strategies Fund Latest Stock News & Market Updates - StockTitan
THW: Revisiting The 11.8% Healthcare Yielder As Thesis Plays Out (NYSE:THW) - Seeking Alpha
Health and Safety - University of Aberdeen
The Wellcome Trust Institutional Strategic Support Fund (ISSF @ Aberdeen) - University of Aberdeen
THQ (Tekla Healthcare Opportunities Fund) Change In Prepaid Assets : $-0.1 Mil (TTM As of Mar. 2024) - GuruFocus.com
Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, Second-Generation Immunomodulator - Business Wire
THQ (Tekla Healthcare Opportunities Fund) Enterprise Value : $1,081.0 Mil (As of Dec. 05, 2024) - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Earnings Power Va - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Cash Flow from Fi - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Purchase Of Busin - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Purchase Of Inves - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Sale Of Business : $0.0 Mil (TTM As of Mar. 2024) - GuruFocus.com
Nature and health — a perfect partnership - Scottish Natural Heritage
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):